These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24588448)

  • 1. Cytochrome P450 pharmacogenetics in African populations: implications for public health.
    Dandara C; Swart M; Mpeta B; Wonkam A; Masimirembwa C
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):769-85. PubMed ID: 24588448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.
    Dandara C; Lombard Z; Du Plooy I; McLellan T; Norris SA; Ramsay M
    Pharmacogenomics; 2011 Dec; 12(12):1663-70. PubMed ID: 22118051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
    Zanger UM; Schwab M
    Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.
    Kohlrausch FB; Carracedo Á; Hutz MH
    Mol Biol Rep; 2014 Mar; 41(3):1453-60. PubMed ID: 24443221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraindividual Variation and Correlation of Cytochrome P450 Activities in Human Liver Microsomes.
    Fang Y; Gao J; Wang T; Tian X; Gao N; Zhou J; Zhang HF; Wen Q; Jin H; Xing YR; Qiao HL
    Mol Pharm; 2018 Nov; 15(11):5312-5318. PubMed ID: 30346185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Special report: genotyping for cytochrome P450 polymorphisms to determine drug-metabolizer status.
    Technol Eval Cent Assess Program Exec Summ; 2004 Dec; 19(9):1-2. PubMed ID: 15651132
    [No Abstract]   [Full Text] [Related]  

  • 8. African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.
    Rajman I; Knapp L; Morgan T; Masimirembwa C
    EBioMedicine; 2017 Mar; 17():67-74. PubMed ID: 28237373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytochrome P450 2C19 gene polymorphism in four Chinese nationality populations].
    Zhang S; Dong Z; Tang L; Zhou Q; Wu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):52-4. PubMed ID: 11836688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.
    Bradford LD
    Pharmacogenomics; 2002 Mar; 3(2):229-43. PubMed ID: 11972444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.
    Solus JF; Arietta BJ; Harris JR; Sexton DP; Steward JQ; McMunn C; Ihrie P; Mehall JM; Edwards TL; Dawson EP
    Pharmacogenomics; 2004 Oct; 5(7):895-931. PubMed ID: 15469410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antimalarial drugs: effect on metabolism and transport.
    Kerb R; Fux R; Mörike K; Kremsner PG; Gil JP; Gleiter CH; Schwab M
    Lancet Infect Dis; 2009 Dec; 9(12):760-74. PubMed ID: 19926036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients.
    Swart M; Skelton M; Ren Y; Smith P; Takuva S; Dandara C
    Pharmacogenet Genomics; 2013 Aug; 23(8):415-27. PubMed ID: 23778320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical differences in CYP1A1 genotype and function.
    Taioli E; Crofts F; Trachman J; Bayo S; Toniolo P; Garte SJ
    Toxicol Lett; 1995 May; 77(1-3):357-62. PubMed ID: 7618162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 variations in different ethnic populations.
    McGraw J; Waller D
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):371-82. PubMed ID: 22288606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C9 allelic variants: ethnic distribution and functional significance.
    Xie HG; Prasad HC; Kim RB; Stein CM
    Adv Drug Deliv Rev; 2002 Nov; 54(10):1257-70. PubMed ID: 12406644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.
    Matimba A; Del-Favero J; Van Broeckhoven C; Masimirembwa C
    Hum Genomics; 2009 Jan; 3(2):169-90. PubMed ID: 19164093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PM frequencies of major CYPs in Asians and Caucasians.
    Mizutani T
    Drug Metab Rev; 2003; 35(2-3):99-106. PubMed ID: 12959412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.